ImmuCell Reports Preliminary Q1 Revenue $10.4M ImmuCell reported preliminary Q1 revenue of $10.4M for the quarter ended Mar 31, 2026 (Apr 9, 2026). Investors should await the formal 10-Q for margins and cash-flow detail.

ImmuCell Reports Preliminary Q1 Revenue $10.4M: ImmuCell reported preliminary Q1 revenue of $10.4M for the quarter ended Mar 31, 2026 (Apr 9, 2026). Investors should await the formal 10-Q for margins and… 👈 Read full analysis #ImmuCell #Q1Revenue #InvestmentNews #AnimalHealth #SmallCapStocks